Home » Stocks » ONTX

Onconova Therapeutics, Inc. (ONTX)

Stock Price: $7.07 USD -0.08 (-1.12%)
Updated Jun 11, 2021 4:00 PM EDT - Market closed
After-hours: $7.03 -0.04 (-0.57%) Jun 11, 7:56 PM
Market Cap 111.57M
Revenue (ttm) 235,000
Net Income (ttm) -24.78M
Shares Out 219.24M
EPS (ttm) -1.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $7.07
Previous Close $7.15
Change ($) -0.08
Change (%) -1.12%
Day's Open 7.15
Day's Range 6.97 - 7.24
Day's Volume 595,217
52-Week Range 2.85 - 28.95

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Onconova Therapeutics, Inc. (ONTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 week ago - Zacks Investment Research

Phase 1 study to evaluate ON 123300 in advanced cancer patients including HR+ HER 2- metastatic breast cancer patients resistant to approved CDK 4/6 inhibitors Phase 1 study to evaluate ON 123300 in adv...

3 weeks ago - GlobeNewsWire

Are these the top penny stocks to buy in 2021? Take a look and decide for yourself The post Top Penny Stocks to Buy Now?

Other stocks mentioned: AEHR, IMMP, UXIN
3 weeks ago - PennyStocks

NEWTOWN, Pa., May 20, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq: ONTX) (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing ...

3 weeks ago - GlobeNewsWire

Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and $4 price target. Onconova Therapeutics is a biopharmaceutical ...

3 weeks ago - Benzinga

Biotech penny stocks continue to heat up; here's 4 under $5 to look into The post Biotech Penny Stocks Are On Fire Today, Here's 3 to Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News an...

Other stocks mentioned: ACRX, AGEN
3 weeks ago - PennyStocks

Conference call and live webcast at 4:30 p.m. ET today

3 weeks ago - GlobeNewsWire

These penny stocks moved big in early morning trading; here's why The post Penny Stocks to Buy in May 2021? Here's 3 Big Pre-Market Gainers appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other stocks mentioned: ARPO, IDEX
3 weeks ago - PennyStocks

Onconova Therapeutics (NASDAQ:ONTX) announces its next round of earnings this Monday, May 17. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings announcement.

4 weeks ago - Benzinga

These seven risky Reddit penny stocks are in the biotech space and the business of developing cancer therapies and treatments. The post 7 Reddit Penny Stocks Promising to Cure Cancer appeared first on I...

Other stocks mentioned: AIKI, ATNM, ATOS, BNGO, CTIC, IMMP
4 weeks ago - InvestorPlace

Company to host conference call and webcast at 4:30 p.m. Eastern Time on Monday, May 17. Company to host conference call and webcast at 4:30 p.m. Eastern Time on Monday, May 17.

1 month ago - GlobeNewsWire

Onconova Therapeutics, Inc. (ONTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Biotech penny stocks continue to see momentum; should you add these 3 to your watchlist? The post Top Biotech Penny Stocks to Buy?

Other stocks mentioned: ASXC, ITRM, ZOM
1 month ago - PennyStocks

Corporate Partner HanX Biopharmaceuticals enrolled third patient in 80 mg group Corporate Partner HanX Biopharmaceuticals enrolled third patient in 80 mg group

2 months ago - GlobeNewsWire

NEWTOWN, Pa., March 29, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products ...

2 months ago - GlobeNewsWire

Onconova's targeted anti-cancer agents enhance the bull thesis for ONTX stock, but the stock's volatile price action raises a red flag. The post Be Cautious as Onconova Therapeutics Stock Flirts With De...

2 months ago - InvestorPlace

Amid risk-on sentiment, penny stocks are surging higher today as investors seek to grab the higher upside these small-cap stocks provide. The post Top Penny Stocks News Today: TNXP, ONTX, AREC, LPCN and...

Other stocks mentioned: AREC, LPCN, TNXP, ZCMD
2 months ago - InvestorPlace

bluebird bio, Inc. (NASDAQ: BLUE), Onconova Therapeutics, Inc. (NASDAQ: ONTX), FSD Pharma Inc. (NASDAQ: HUGE) and Immatics N.V. (NASDAQ: IMTX) are among the biggest biopharma movers in Wednesday's session.

Other stocks mentioned: BLUE, HUGE, IMTX
2 months ago - Benzinga

Conference call begins at 4:30 p.m. Eastern time today

3 months ago - GlobeNewsWire

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time on Thursday, March 11, 2021

3 months ago - GlobeNewsWire

NEWTOWN, PA., March 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patients wi...

3 months ago - GlobeNewsWire

Onconova Therapeutics (NASDAQ: ONTX) shares are trading higher today after the company announced it regained compliance with the Nasdaq listing requirement. Onconova Therapeutics, Inc. is a biopharmaceu...

3 months ago - Benzinga

Investors are eager to hear more about the biotech's experimental cancer treatments.

3 months ago - The Motley Fool

Onconova Therapeutics (ONTX) stock is on the rise Wednesday following the closing of its most recent public offering of 28.75 million shares. The post ONTX Stock: Why Biopharma Onconova Therapeutics Is ...

3 months ago - InvestorPlace

NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer,...

3 months ago - GlobeNewsWire

NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patients wit...

3 months ago - GlobeNewsWire

NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer,...

4 months ago - GlobeNewsWire

NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer,...

4 months ago - GlobeNewsWire

NEWTOWN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer,...

5 months ago - GlobeNewsWire

Onconova Therapeutics (ONTX) stock is on the move Tuesday with heavy trading despite a lack of recent news from the company. The post Onconova Therapeutics: 7 Things for ONTX Stock Investors to Know Abo...

6 months ago - InvestorPlace

NEWTOWN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announ...

6 months ago - GlobeNewsWire

Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Conference call begins at 4:30 p.m. ET today

7 months ago - GlobeNewsWire

Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 12 Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 12

7 months ago - GlobeNewsWire

NEWTOWN, Pa., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announ...

7 months ago - GlobeNewsWire

Company remains on track to file a US IND in Q4 2020, with commencement of a US Phase 1 study targeted for Q1 2021

8 months ago - GlobeNewsWire

Onconova remains focused on development of its proprietary pipeline of targeted agents as it enters a new phase as a biopharmaceutical company Onconova remains focused on development of its proprietary ...

9 months ago - GlobeNewsWire

Onconova's (ONTX) shares fall more than 60% after its phase III study on intravenous rigosertib in patients with higher-risk myelodysplastic syndromes did not meet the primary endpoint.

9 months ago - Zacks Investment Research

Onconova Therapeutics Inc. (NASDAQ: ONTX) was absolutely crushed to start out the week after the company reported results from its late-stage cancer study.

9 months ago - 24/7 Wall Street

IV rigosertib did not meet primary endpoint of significantly improved survival versus best supportive care in higher-risk myelodysplastic syndromes (HR-MDS)

9 months ago - GlobeNewsWire

Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Shares of Onconova Therapeutics (NASDAQ:ONTX) decreased 1.89% in after-market trading after the company reported Q2 results.

10 months ago - Benzinga

Conference call and webcast scheduled today, August 12, at 4:30 p.m. ET

10 months ago - GlobeNewsWire

Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12 Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12

10 months ago - GlobeNewsWire

NEWTOWN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat canc...

10 months ago - GlobeNewsWire

Investors will focus on pipeline updates when Onconova (ONTX) reports Q2 results.

10 months ago - Zacks Investment Research

Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020 Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020

10 months ago - GlobeNewsWire

NEWTOWN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat canc...

10 months ago - GlobeNewsWire

RAS-focused mechanism of action and manageable side effect profile indicate potential promise for oral rigosertib as part of future combination therapies

11 months ago - GlobeNewsWire

Onconova (ONTX) starts investigator-initiated phase I/IIa study of oral rigosertib plus Bristol-Myers Squibb's Opdivo in advanced metastatic KRAS-mutated lung adenocarcinoma.

11 months ago - Zacks Investment Research

About ONTX

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its novel proprietary multi-kinase inhibitor ON 123300 to target CDK4/6 and other tyrosine kinases. The company's product candidate oral rigosertib, which is in Phase 1 study of rigosertib in combination with a PD-1 inhibitor for patients with progressiv... [Read more...]

Industry
Biotechnology
IPO Date
Jul 25, 2013
CEO
Steven Fruchtman
Employees
11
Stock Exchange
NASDAQ
Ticker Symbol
ONTX
Full Company Profile

Financial Performance

In 2020, ONTX's revenue was $231,000, a decrease of -89.42% compared to the previous year's $2.18 million. Losses were -$25.16 million, 17.0% more than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for ONTX stock is "Buy." The 12-month stock price forecast is 3.05, which is a decrease of -56.86% from the latest price.

Price Target
$3.05
(-56.86% downside)
Analyst Consensus: Buy